OSM: Do Changes in Plasma Osmolality Influence Ventilation?

Sponsor
Vibeke Moen (Other)
Overall Status
Completed
CT.gov ID
NCT01008644
Collaborator
(none)
26
1
2
12
2.2

Study Details

Study Description

Brief Summary

Primary hypothesis: osmolality changes influence the sensitivity of the respiratory center to carbon dioxide, hyponatraemia causing hyperventilation, and hypernatraemia depressing ventilation.

Secondary hypothesis: There are gender differences in the sensitivity to osmolality changes.

10 women and 10 men will on different occasions drink water or receive hypertonic saline intravenously, in order to lower or increase plasma osmolality. The women will participate during both faces of the menstruation cycle. On each occasion the subject´s sensitivity to carbon dioxide will be tested, and blood samples will be drawn for analysis of blood gases,electrolyte and osmolality.Subjects who interrupt participation before completion of all planned occasions, will be substituted, so that 10 subjects of either sex will have participated as planned. All results from all participants will be analyzed.

Condition or Disease Intervention/Treatment Phase
  • Other: Water
  • Other: Saline 3%
Early Phase 1

Detailed Description

Healthy volunteers will on different occasions be subject to reduced plasma osmolality caused by drinking water, and increased osmolality caused by intravenous infusion of hypertonic saline.Before and after each osmolality change, sensitivity to carbon dioxide will be tested by partial rebreathing through a so called Bain-system. Throughout the whole experiment heart rate, blood pressure and oxygen saturation will be recorded.Blood samples will be collected before each rebreathing test and every 20 minutes during the two hours of water or salt load. Urine will be collected and analysed.

Study Design

Study Type:
Interventional
Actual Enrollment :
26 participants
Allocation:
Non-Randomized
Intervention Model:
Factorial Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Do Plasma Osmolality Changes Influence Ventilation, and Are There Gender Differences?
Study Start Date :
Nov 1, 2009
Actual Primary Completion Date :
Nov 1, 2010
Actual Study Completion Date :
Nov 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: Saline

The subjects will receive saline 3% intravenously for 2 hours, the volume calculated as 0.1 ml/kg/min.

Other: Water
The subjects will drink tap water for 2 hours, volume calculated according to weight: 20ml/kg/hour.
Other Names:
  • saline 3%
  • Other: Saline 3%
    The subjects will receive saline 3% intravenously for 2 hours, the volume calculated as 0.1 ml/kg/min

    Experimental: Water

    The subjects will drink tap water for 2 hours, the volume calculated as 20ml/kg/hour

    Other: Water
    The subjects will drink tap water for 2 hours, volume calculated according to weight: 20ml/kg/hour.
    Other Names:
  • saline 3%
  • Other: Saline 3%
    The subjects will receive saline 3% intravenously for 2 hours, the volume calculated as 0.1 ml/kg/min

    Outcome Measures

    Primary Outcome Measures

    1. pCO2 [ten minutes]

      pCO2,osmolality and sensitivity to CO2 will be recorded 10 minutes before before and 10 minutes after administering water or saline for two hours.The results will be analyzed for differences before and after osmolality changes in every single individual, and differences between females in luteal or follicular menstruation phase.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Females with regular menstruations, males
    Exclusion Criteria:
    • Consumption of nicotine, BMI > 26,

    • pregnancy,any hormone treatment,

    • treatment with diuretics,

    • diabetes or kidney disease,

    • BMI > 26,

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Anaesthesia and Intensive care, Kalmar County Hospital Kalmar Sweden 39185

    Sponsors and Collaborators

    • Vibeke Moen

    Investigators

    • Study Director: Lars Irestedt. MD PhD, Department of Anaesthesia and Intensive Care , Karolinska University Hospital, Stockholm

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Vibeke Moen, MD, Department of Anaesthesia, Kalmar County Hospital
    ClinicalTrials.gov Identifier:
    NCT01008644
    Other Study ID Numbers:
    • M-126-09
    First Posted:
    Nov 6, 2009
    Last Update Posted:
    Oct 17, 2012
    Last Verified:
    Oct 1, 2012
    Keywords provided by Vibeke Moen, MD, Department of Anaesthesia, Kalmar County Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 17, 2012